According to Natco Pharma 's latest financial reports the company's current EPS (TTM) is โน46.77. In 2022 the company made an earnings per share (EPS) of โน22.69 an increase over its 2021 EPS that were of โน17.29.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน44.88 | 97.76% |
2022 | โน22.69 | 31.27% |
2021 | โน17.29 | -43.11% |
2020 | โน30.39 | -7.23% |
2019 | โน32.76 | -41.42% |
2018 | โน55.92 | 28.54% |
2017 | โน43.50 | 58.87% |
2016 | โน27.38 | 130.83% |
2015 | โน11.86 | 34.13% |
2014 | โน8.84 | 9.4% |
2013 | โน8.08 | 8.42% |
2012 | โน7.46 |